OVID earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -6.88. Updated 2026-07-23.
Ovid Therapeutics (OVID) Research Hub
Ovid Therapeutics (OVID) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.15 USD (-0.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.88, market cap 0.31B. This hub links to the full technical, earnings and options research available for OVID.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.15 USD (-0.46%) |
| 52-week range | 2.09 USD – 2.95 USD |
| Trend regime | Range |
| 14-day RSI | 41.1 (Bearish) |
| Trailing P/E | -6.88 |
| Market cap | 0.31B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for OVID
Covered Call on OVID: how it works, illustrative setup around the real 2.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OVID: how it works, illustrative setup around the real 2.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OVID: how it works, illustrative setup around the real 2.15 USD price, max profit/loss, breakeven and when to use it. Educational.
OVID technical analysis: range, last 2.15 USD, RSI 41.1, 52w range 2.09 USD–2.95 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is OVID in?
Ovid Therapeutics (OVID) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OVID in an uptrend or downtrend?
As of 2026-10-26, OVID is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OVID's trailing P/E ratio?
OVID's trailing P/E is -6.88, with a market cap of 0.31B. See the earnings research page for full valuation detail.
When does OVID next report earnings?
OVID is next scheduled to report earnings on 2026-08-12.